PUBLIC COMPANY
saveJanssen Biotech Inc
updated 2mo ago
Johnson & Johnson Innovative Medicine is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval214 co-mentions · 107 sources
- tagSmall Molecule32 co-mentions · 32 sources
- drugERLEADA30 co-mentions · 15 sources
- drugdaratumumab + Gene Therapy30 co-mentions · 15 sources
- drugapalutamide30 co-mentions · 15 sources
- drugDARZALEX FASPRO30 co-mentions · 15 sources
- drugdaratumumab30 co-mentions · 15 sources
- drugustekinumab28 co-mentions · 14 sources
pipeline
22
marketed
8
phase 3
0
catalysts ytd
8
approvals ytd
8
recalls ytd
0
Pipeline(22)
view full pipeline →pipeline depth22 products
1Phase 11Phase 28Marketed12Unknown
Marketed
(daratumumab + hyaluronidase (human recombinant))
Multiple Myeloma (Kahler Disease)
Marketed(macitentan + tadalafil)
Pulmonary Arterial Hypertension
MarketedSimponi Aria
Rheumatoid Arthritis
Marketedamivantamab
Non-Small Cell Lung Cancer
Marketedciltacabtagene autoleucel
Refractory Multiple Myeloma
Marketedgolimumab
Ankylosing Spondylitis (Bekhterev's Disease)
Marketedinfliximab
Plaque Psoriasis (Psoriasis Vulgaris)
Marketedteclistamab
Refractory Multiple Myeloma
Phase 2prizloncabtagene autoleucel
Diffuse Large B-Cell Lymphoma
Phase 1CCAR-066
Diffuse Large B-Cell Lymphoma
drugAKEEGA
drugBALVERSA
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that